Australia Patent: Genzyme, Icahn School of Medicine at Mount Sinai File Application for 'DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY'

Press/Media

Period6 Nov 2020

Media coverage

1

Media coverage

  • TitleAustralia Patent: Genzyme, Icahn School of Medicine at Mount Sinai File Application for 'DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date6/11/20
    PersonsRobert Desnick
View all 1
View less